MDLN

Medline
D

MDLN

Arincen64/100B

Medline cash flow statement 2022–2026

Medline's free cash flow over the last twelve months was 1.90B USD: operating cash flow of 2.38B USD less 486.00M USD of capital spending. That is 6.2% of its revenue and 1.99 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
26 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
Net income
876.00M1.16B1.20B234.00M-25.00M
Depreciation and amortization
1.03B1.01B977.00M951.00M933.00M
Stock-based compensation
—0.000.000.000.00
Change in working capital
-177.00M-783.00M-675.00M199.00M-919.00M
Change in receivables
-397.00M-355.00M-256.00M-153.00M-376.00M
Change in inventory
-285.00M-264.00M-545.00M444.00M-195.00M
Change in payables
216.00M73.00M106.00M136.00M-103.00M
Change in other working capital
289.00M-237.00M20.00M-228.00M-245.00M
Other non-cash items
431.00M357.00M291.00M325.00M212.00M
Operating cash flow
2.38B1.74B1.77B1.69B187.00M
Operating cash flow growth
—-1.41%+4.99%+801.07%—
Capital expenditure
-486.00M-447.00M-354.00M-275.00M-254.00M
Acquisitions
—6.00M-1.13B-16.00M-17.00M
Purchases of investments
—0.000.00-16.00M0.00
Sales and maturities of investments
—0.000.005.00M7.00M
Other investing
—-33.00M-3.00M0.000.00
Investing cash flow
-1.68B-474.00M-1.49B-312.00M-264.00M
Debt issued (repaid)
—-4.09B-75.00M-77.00M-61.00M
Shares issued
—7.05B0.000.000.00
Share buybacks
—-2.00B-20.00M0.000.00
Dividends paid
—-518.00M0.00-114.00M0.00
Other financing
-217.00M-36.00M-1.52B0.00-23.00M
Financing cash flow
677.00M399.00M-1.61B-191.00M-84.00M
Net change in cash
-574.00M1.69B-1.34B1.59B0.00
Free cash flow
1.90B1.30B1.42B1.41B-67.00M
Free cash flow growth
—-8.34%+0.35%——
Free cash flow margin
6.18%4.56%5.55%6.07%-0.31%
Free cash flow per share
1.991.601.801.79-0.09
Free cash flow per share growth
—-11.15%+0.35%——
Income taxes paid
—0.000.000.000.00

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Figures underlined with dots are from the company's SEC filings, where our data provider's differ.

Common questions about Medline's cash flow

Source: Financial Modeling Prep